{'Year': '2014', 'Month': 'May'}
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer.
This study was conducted to evaluate potential pharmacokinetic interactions between docetaxel and atrasentan as part of a phase I/II clinical trial.